10 Results for "

transient receptor potential vanilloid type 1

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "transient receptor potential vanilloid type 1" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-19960
CAS No.: 393514-24-4
BCTC is an orally active current inhibitor of vanilloid receptor type 1 (VR1). BCTC is a transient receptor potential cation channel subfamily M member 8 (TRPM8) and transient receptor potential vanilloid 1 (TRPV1) antagonist. BCTC is an insulin sensitizer and secretor. BCTC has anticancer and analgesic effects .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-12195
CAS No.: 460746-46-7
Purity:  99.23%
ABT-239 is a novel, highly efficacious, non-imidazole class of H3R antagonist and a transient receptor potential vanilloid type 1 (TRPV1) antagonist.
loading...
    loading...
Cat. No.: HY-101323
CAS No.: 58493-49-5
Purity:  ≥98.0%
Synonyms: NE-19550; N-Vanillyloleamide
Target:  

TRP Channel

Research Areas:  

Neurological Disease

Olvanil (NE-19550) is an analgesic and an agonist of transient receptor potential vanilloid type 1 (TRPV1) channels with an EC50 of 0.7 nM .
loading...
    loading...
Cat. No.: HY-113654
CAS No.: 1026876-55-0
Target:  

TRP Channel

Research Areas:  

Others

AMG 7905 is a hypothermia-inducing transient receptor potential vanilloid type 1 (TRPV1) antagonist. AMG 7905 potentiates TRPV1 channels activation by protons and drives the reflectory inhibition of thermogenesis and tail-skin vasoconstriction, while potently blocking channel activation by capsaicin .
loading...
    loading...
Cat. No.: HY-119121
CAS No.: 951135-00-5
Target:  

TRP Channel

Research Areas:  

Neurological Disease

JNJ-38893777 is an orally active and highly selective transient receptor potential vanilloid type 1 (TRPV1) channel antagonist. JNJ-38893777 inhibits neuronal hyperactivation and reduces inflammatory hyperalgesia. JNJ-38893777 is promising for research of migraine headaches, neuropathic and inflammatory pain .
loading...
    loading...
Cat. No.: HY-19960R
CAS No.: 393514-24-4
BCTC (Standard) is the analytical standard of BCTC. This product is intended for research and analytical applications. BCTC is an orally active current inhibitor of vanilloid receptor type 1 (VR1). BCTC is a transient receptor potential cation channel subfamily M member 8 (TRPM8) and transient receptor potential vanilloid 1 (TRPV1) antagonist. BCTC is an insulin sensitizer and secretor. BCTC has anticancer and analgesic effects .
loading...
    loading...
Cat. No.: HY-101323R
CAS No.: 58493-49-5
Synonyms: NE-19550 (Standard); N-Vanillyloleamide (Standard)
Research Areas:  

Neurological Disease

Olvanil (Standard) is the analytical standard of Olvanil. This product is intended for research and analytical applications. Olvanil (NE-19550) is an analgesic and an agonist of transient receptor potential vanilloid type 1 (TRPV1) channels with an EC50 of 0.7 nM .
loading...
    loading...
Cat. No.: HY-115133
CAS No.: 1008529-42-7
Target:  

TRP Channel

Research Areas:  

Neurological Disease

ABT-116 is an orally active antagonist of transient receptor potential vanilloid type 1 (TRPV1). ABT-116 has analgesic efficacy. ABT-116 can be used for the research of neurological disease .
loading...
    loading...
Cat. No.: HY-113654A
Target:  

TRP Channel

Research Areas:  

Cardiovascular Disease

AMG 7905 TFA is a hypothermia-inducing transient receptor potential vanilloid type 1 (TRPV1) antagonist. AMG 7905 TFA potentiates TRPV1 channels activation by protons and drives the reflectory inhibition of thermogenesis and tail-skin vasoconstriction, while potently blocking channel activation by capsaicin .
loading...
    loading...
Cat. No.: HY-121465
CAS No.: 67964-87-8
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease

Stearoyl serotonin is a hybrid molecule patterned after arachidonoyl serotonin. Arachidonoyl serotonin is a dual antagonist of fatty acid amide hydrolase (FAAH) and the transient receptor potential vanilloid-type 1 (TRPV1) channel, reducing both acute and chronic peripheral pain. The effects of replacing the arachidonoyl portion with the saturated 18-carbon stearoyl moiety have not been studied. However, replacement of arachidonate with saturated 11- or 12-carbon fatty acids produces compounds that potently inhibit capsaicin-induced TRPV1 channel activation (IC50=0.76 μM) without blocking FAAH-mediated hydrolysis of arachidonoyl ethanolamine (IC50 > 50 μM).
loading...
    loading...